BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17335878)

  • 21. Nuclear inositide signaling and cell cycle.
    Ratti S; Ramazzotti G; Faenza I; Fiume R; Mongiorgi S; Billi AM; McCubrey JA; Suh PG; Manzoli L; Cocco L; Follo MY
    Adv Biol Regul; 2018 Jan; 67():1-6. PubMed ID: 29102395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal transduction within the nucleus: revisiting phosphoinositide inositide-specific phospholipase Cbeta1.
    Cocco L; Martelli AM; Fiume R; Faenza I; Billi AM; Manzoli FA
    Adv Enzyme Regul; 2006; 46():2-11. PubMed ID: 16846636
    [No Abstract]   [Full Text] [Related]  

  • 23. Deletion of the inositide-specific phospholipase c beta1 gene is a rare event in myelodysplastic syndrome and thus of limited value to predict leukemic progression.
    Verburgh E; Verhoef G; Vandenberghe P; Hagemeijer A
    Leukemia; 2005 Nov; 19(11):2011-3. PubMed ID: 16193086
    [No Abstract]   [Full Text] [Related]  

  • 24. Glycogen Synthase Kinase-3 and phospholipase C-beta signalling: Roles and possible interactions in myelodysplastic syndromes and acute myeloid leukemia.
    Ratti S; Mongiorgi S; Rusciano I; Manzoli L; Follo MY
    Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118649. PubMed ID: 31954103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inositide-specific phospholipase c beta1 gene deletion is a rare event in myelodysplastic syndromes.
    Herens C; Ketelslegers O; Tassin F; Hansen S; Bours V
    Leukemia; 2006 Mar; 20(3):521-2; author reply 522-3. PubMed ID: 16424863
    [No Abstract]   [Full Text] [Related]  

  • 26. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
    Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
    Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelodysplastic syndromes: molecular pathogenesis and genomic changes.
    Nolte F; Hofmann WK
    Ann Hematol; 2008 Oct; 87(10):777-95. PubMed ID: 18516602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous calcium oscillations and nuclear PLC-beta1 in human GV oocytes.
    Miyara F; Pesty A; Migne C; Djediat C; Huang XB; Dumont-Hassan M; Debey P; Lefèvre B
    Mol Reprod Dev; 2008 Feb; 75(2):392-402. PubMed ID: 17620288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear PI-PLCβ1 and myelodysplastic syndromes: genetics and epigenetics.
    Follo MY; Mongiorgi S; Finelli C; Piazzi M; Faenza I; Ramazzotti G; Santi P; McCubrey JA; Martelli AM; Cocco L
    Curr Pharm Des; 2012; 18(13):1751-4. PubMed ID: 22352752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inositol polyphosphate kinases: regulators of nuclear function.
    Seeds AM; York JD
    Biochem Soc Symp; 2007; (74):183-97. PubMed ID: 17233590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C.
    Poli A; Billi AM; Mongiorgi S; Ratti S; McCubrey JA; Suh PG; Cocco L; Ramazzotti G
    J Cell Physiol; 2016 Aug; 231(8):1645-55. PubMed ID: 26626942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The phosphoinositide-phospholipase C system. A branched path of transmembrane signal transduction].
    Höer A; Oberdisse E
    Med Monatsschr Pharm; 1990 Aug; 13(8):243-52. PubMed ID: 2169018
    [No Abstract]   [Full Text] [Related]  

  • 33. Nuclear/cytoplasmic localization of Akt activity in the cell cycle.
    Rosner M; Hanneder M; Freilinger A; Hengstschläger M
    Amino Acids; 2007; 32(3):341-5. PubMed ID: 17357828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ribonucleases of the leukocytic nuclei and cytoplasm of cows normally and in leukemia].
    Shliakhovenko VA; Negriĭ GZ; Butenko ZA
    Ukr Biokhim Zh; 1973; 45(6):740-4. PubMed ID: 4791117
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum thymidine kinase in hematologic malignancies.
    Luoni R; Ucci G; Riccardi A; Spriano P; Danova M; Cassano E; Molinari E; Ascari E
    Haematologica; 1988; 73(1):31-5. PubMed ID: 3131202
    [No Abstract]   [Full Text] [Related]  

  • 36. Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells.
    Qi X; Chen Z; Liu D; Cen J; Gu M
    Int J Mol Med; 2008 Jul; 22(1):61-8. PubMed ID: 18575777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells.
    Nakamura S; Okinaka K; Hirano I; Ono T; Sugimoto Y; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
    Leuk Res; 2008 Sep; 32(9):1358-65. PubMed ID: 18384876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deciphering the mammalian stress response - a stressful task.
    Ronai Z
    Oncogene; 1999 Nov; 18(45):6084-6. PubMed ID: 10557098
    [No Abstract]   [Full Text] [Related]  

  • 39. Alternative splice variants of phospholipase C-beta2 are expressed in platelets: effect on Galphaq-dependent activation and localization.
    Sun L; Mao G; Kunapuli SP; Dhanasekaran DN; Rao AK
    Platelets; 2007 May; 18(3):217-23. PubMed ID: 17497434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular bases of leukemia, MPD and MDS].
    Kitamura T
    Rinsho Ketsueki; 2009 Mar; 50(3):174-81. PubMed ID: 19352084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.